Fibroblasts from patients with heterozygous point mutations in the PDX1 transactivation domain were successfully reprogrammed to iPSCs and can be used to study diabetes-associated pathomechanisms (87–89). The gene discussed is PDX1; the disease is diabetes mellitus.